Centre for Evidence-based Healthcare, Division of Epidemiology and Biostatistics, Department of Global Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
School of Public Health, College of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda.
Pan Afr Med J. 2022 Dec 30;43:215. doi: 10.11604/pamj.2022.43.215.31547. eCollection 2022.
World Health Organization (WHO) recommends the implementation of 'Best buys', cost-effective interventions that address risk factors of non-communicable diseases (NCDs). However, country responses to the implementation of these have been slow and undocumented. The aim of this study was to identify and understand challenges and enablers for the implementation of WHO 'Best buys' for risk factors of diabetes and hypertension in South Africa (SA).
a mixed methods research with a sequential dominant status design was used starting with a document review to take stock of WHO 'Best buys' in policy in SA. A qualitative study using key informant interviews was then done to identify and understand challenges and enablers for implementation. A triangulation approach for the analysis of both document review and qualitative data was used.
SA has made good progress in including the WHO 'Best buys' in the policy. However, several challenges hamper the successful implementation. Most challenges were related to upstream policy implementation processes such as competing interests of actors, lack of balance between economic vs health gains, and lack of funding. Enabling factors included multi-sectoral engagement and collaboration; community ownership and empowerment; building partnerships for co-creation of enabling environments; leveraging on the existing infrastructure of other health programs; contextualization of policies and programs; and political will and leadership.
SA has made good progress in including WHO 'Best buys' targeting risk factors of diabetes and hypertension in policy, however, various contextual barriers influence effective implementation. Hence, there is a need to leverage enabling factors to foster the implementation of WHO 'Best buys' interventions targeting risk factors of diabetes and hypertension in South Africa.
世界卫生组织(WHO)建议实施“最佳购买”,即针对非传染性疾病(NCD)风险因素的具有成本效益的干预措施。然而,各国对这些措施的实施反应缓慢且没有记录。本研究的目的是确定和了解南非(SA)实施针对糖尿病和高血压风险因素的 WHO“最佳购买”的挑战和推动因素。
采用混合方法研究,采用顺序主导地位设计,首先对 SA 的政策进行文件审查,以了解 WHO“最佳购买”。然后进行定性研究,使用关键知情人访谈,以确定和了解实施的挑战和推动因素。使用三角分析方法对文件审查和定性数据进行分析。
SA 在将 WHO“最佳购买”纳入政策方面取得了良好进展。然而,一些挑战阻碍了成功实施。大多数挑战与上游政策实施过程有关,例如行为者的利益冲突、经济收益与健康收益之间的不平衡,以及缺乏资金。推动因素包括多部门参与和合作;社区拥有权和赋权;建立伙伴关系,共同创造有利环境;利用其他卫生计划的现有基础设施;政策和方案的本土化;以及政治意愿和领导力。
SA 在将针对糖尿病和高血压风险因素的 WHO“最佳购买”纳入政策方面取得了良好进展,但各种背景障碍影响了有效实施。因此,需要利用推动因素来促进针对糖尿病和高血压风险因素的 WHO“最佳购买”干预措施在南非的实施。